drugset / Trial / NCT04727606

Research Project: Pilot Study on Oral Urea Use in Patients at High Risk of Kidney Stone Recurrence

NCT04727606 ↗

NaSingle-groupOpen-labelOther

Summary

In clinical practice, many patients are not able to modify their habits to achieve a high level of diuresis and fluid intake and therefore are at an elevated risk for stone recurrence. The investigators think that Ure-Na (osmotic agent) taking could help to increase urine volume and decrease urine concentration, which would be of benefit in the prevention of kidney stones.

Timeline

Start
2023-01-15
Primary completion
2024-01-15
Completion
2024-06-15

Outcome

Outcome not reported

Stopped: “We never got Health Canada approval”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ure-Na Other / unclassified 30 g Oral

Indications